Cellular Immunotherapy
Dendritic Cell Therapy in China 2026: What's Legal, Who Can Get It
DC therapy is not routine care in mainland China. The only two legal routes, the 2026 rule changes, and how to spot a clinic selling a cure.
Read Article →Expert guides, cost comparisons, and patient stories to help you make informed decisions about healthcare in China
9 chapters. Everything from hospital selection to recovery at home. Free.
Explore our comprehensive guides on medical procedures, costs, and hospitals in China.
Medical procedures you can only get in China — or get dramatically cheaper, faster, and at higher volume than anywhere else.
Three categories where China is genuinely ahead of the world — not just cheaper.
Acupuncture, herbal medicine, moxibustion, cupping, baduanjin — proven in clinical trials, integrated with Western care at top hospitals.
7 approved CAR-T therapies (more than US/EU), world's largest CRISPR pipeline, broader stem cell access through Boao Lecheng.
Ophthalmology, orthopedics, cardiac surgery, microsurgery, IVF — where Chinese hospitals do the most cases in the world.
DC therapy is not routine care in mainland China. The only two legal routes, the 2026 rule changes, and how to spot a clinic selling a cure.
Read Article →Cervical cancer in China: surgery for early stage, chemoradiation plus brachytherapy for locally advanced disease. Costs, top hospitals, and the staging path.
Read Article →Low EF (≤35%) and refractory heart failure: how doctors choose CRT, ICD, CCM, CABG, valve repair, LVAD or transplant — costs and the decision path.
Read Article →Independent matching, a free cost calculator, 52 verified hospital pages, three service tiers — how we help you choose a hospital in China.
Read Article →1.28 million international patients, CAR-T at a third of US prices, 48-hour workups. Why foreigners fly to China for cancer care in 2026 — data, real cases, costs.
Read Article →A New Zealand man became the first international patient to complete satri-cel, China's world-first solid-tumor CAR-T. The real case, timeline, and how to apply.
Read Article →China's flagship device expo wrapped in Beijing: surgical robotics, AI diagnostics, high-end imaging — and why made-in-China technology keeps treatment affordable.
Read Article →The world's first solid-tumor CAR-T targets CLDN18.2 in advanced gastric cancer. Lancet CT041-ST-01 data, who qualifies, the real risks, and how to apply in China.
Read Article →China's only NMPA-approved oncolytic virus fights cold tumors: how the engineered adenovirus works, ASCO 2024 evidence, safety, and how international patients can access it.
Read Article →BCMA CAR-T for relapsed/refractory multiple myeloma in China: $89K-$151K commercial, $30K-$80K trials. Approved products, top hospitals, waiting time — 2026 guide.
Read Article →A Lahore hospital rebuilt a 26-year-old's hip with a Chinese 3D-printed pelvic implant after chondrosarcoma. Why China leads custom implant surgery — and how international patients access it.
Read Article →Indonesia's BPOM and China's NMPA are renewing their drug-regulation MoU, covering CAR-T (ATMP), clinical trials and traditional medicine. What this means for Indonesian patients heading to China.
Read Article →Shanghai startup StairMed unveiled a vein-based brain implant that could be placed in 10 minutes, while China already holds the world's first approved invasive BCI. What international patients should know.
Read Article →NMPA cleared TransThera's tinengotinib (Yochanra) for bile duct cancer that stopped responding to FGFR inhibitors — a world first, with 28% ORR and an 8.5-month median duration of response from the FIRST-08 trial.
Read Article →China approved Leads Biolabs' Opamtistomig (LBL-024) PD-L1 × 4-1BB bispecific for combination trials in MSS/pMMR metastatic colorectal cancer — the 95% of CRC patients who do not respond to standard checkpoint inhibitors.
Read Article →Hainan's Boao Lecheng pilot zone now offers 600+ drugs, devices and therapies approved for the first time in China, added a Korean aesthetic hospital, and runs TCM wellness programs. Here is what international patients can access.
Read Article →CellOrigin is testing mRNA-LNP 'in vivo CAR' therapy for liver cancer — T cells programmed inside the body, not in a lab. GPC3 target, Walvax manufacturing deal, first patients already dosed in 2026.
Read Article →Updated HARMONi data show China-developed ivonescimab cut death risk 24% in EGFR-mutant lung cancer. FDA decision November 14, 2026; the drug is already in routine use in China.
Read Article →China's PARP inhibitor senaparib was licensed to Pharmanovia for 66 countries on July 31, 2026. NRDL pricing, treatment costs, and access for international ovarian cancer patients in China.
Read Article →TCM professors treated a child's mid-air chest pain on a Paris–Beijing flight. The Neiguan (PC6) acupressure evidence, Chinese hospital access, and costs for international patients.
Read Article →Sanfu paste (三伏贴), the dog-day TCM patch for asthma and allergic rhinitis, returns for 2026 with final-round bookings open before Aug 15. Evidence, hospitals, and costs for international patients.
Read Article →From the world's first autonomous robotic dental implant (Xi'an) to China-only CAR-T therapies and integrated Chinese-Western medicine — discover the treatments that make China a truly unique medical destination.
Read Article →Jinan respiratory hospital rankings 2026: Shandong Provincial Hospital, Qilu Hospital & Jinan Central ranked for pulmonology, lung cancer, COPD & asthma treatment. Costs, English s
Read Article →Learn how to choose the best hospital in China for medical tourism. 5 key criteria, JCI certification guide, and city-by-city hospital recommendations.
Read Article →Discover top 10 eye hospitals in China for LASIK, SMILE, and vision correction surgery. Compare costs, technologies, and find the best ophthalmologists for international patients.
Read Article →Comprehensive guide for international patients seeking medical treatment in China. Learn about the process, preparation, and what makes China a viable option for quality healthcare
Read Article →Complete guide to preparing for medical travel to China. Documents, packing list, pre-treatment tips, and what to expect. Make your medical journey smooth and stress-free.
Read Article →Navigate medical tourism between Japan and China. Compare treatments, costs, and discover when China offers advantages for Japanese patients seeking affordable care.
Read Article →Rotator cuff surgery in China costs $3,500–$12,000 in 2026 vs $15,000–$50,000 in the US. Compare prices at top JCI-accredited orthopedic hospitals in Beijing, Shanghai & Guangzhou
Read Article →Heart surgery in China costs 85% less than US. Compare prices, top cardiac hospitals, and patient experiences. Complete 2026 guide.
Read Article →Start with a free case review and get guidance on the right hospital and package for your situation.
Start Free Case ReviewFinding the right hospital in China can be overwhelming. Let us help — free, no commitment.
⏳ Most cases get a hospital match within 24 hours